Cargando…
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Enzymatically stable and specific neuropeptide Y1 receptor (NPYR1) agonists, such as sea lamprey PYY(1-36) (SL-PYY(1-36)), are believed to improve glucose regulation in diabetes by targeting pancreatic islets. In this study, streptozotocin (STZ) diabetic transgenic Glu(CreERT2);ROSA26-eYFP and Ins1...
Autores principales: | Lafferty, Ryan A., Tanday, Neil, Moffett, R. Charlotte, Reimann, Frank, Gribble, Fiona M., Flatt, Peter R., Irwin, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949013/ https://www.ncbi.nlm.nih.gov/pubmed/33716983 http://dx.doi.org/10.3389/fendo.2021.633625 |
Ejemplares similares
-
Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells
por: Mohan, Shruti, et al.
Publicado: (2021) -
Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
por: Tanday, Neil, et al.
Publicado: (2021) -
Sex-based impact of pancreatic islet stressors in Glu(CreERT2)/Rosa26-eYFP mice
por: Tanday, Neil, et al.
Publicado: (2023) -
Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
por: Tanday, Neil, et al.
Publicado: (2022) -
Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
por: Tanday, Neil, et al.
Publicado: (2021)